Open Beta
MetriLume

US marketsAAWH

SEC-sourced researchBeta

AAWH

Ascend Wellness Holdings, Inc.

Company comparison ↗

Data passport

CIK
0001756390
Exchange
OTC
Business activity
Medicinal Chemicals & Botanical Products · SIC 2833
Financial inputs
6/6
Filing date
Aug 31, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 518,590,000.0000 USD; December 2024: 561,599,000.0000 USD; December 2025: 500,581,000.0000 USD561.6M USD0 USD0December 2023December 2024December 2025
AAWH · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2023518,590,000.0000Mar 12, 2026
December 2024561,599,000.0000Mar 12, 2026
December 2025500,581,000.0000Mar 12, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025500,581,000.0000-118,193,000.000038,053,000.0000907,929,000.0000954,546,000.0000Mar 12, 2026
December 2024561,599,000.0000-84,994,000.000073,292,000.0000900,431,000.0000828,630,000.0000Mar 12, 2026
December 2023518,590,000.0000-48,214,000.000075,334,000.0000——Mar 12, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

41/100
Profitability3
Growth39
Balance sheet0
Cash generation65
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$500.58MJan 1, 2025 – Dec 31, 2025Mar 12, 202610-K
Previous period revenueRevenues$561.6MJan 1, 2024 – Dec 31, 2024Mar 12, 202610-K
Net incomeProfitLoss-$118.19MJan 1, 2025 – Dec 31, 2025Mar 12, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$38.05MJan 1, 2025 – Dec 31, 2025Mar 12, 202610-K
Total assetsAssets$907.93MDec 31, 2025Mar 12, 202610-K
Total liabilitiesLiabilities$954.55MDec 31, 2025Mar 12, 202610-K

New filings

Explore methodology ↗